+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Ampio Pharmaceuticals Inc
  • Anika Therapeutics Inc
  • Bionpharma Inc
  • Halyard Health Inc
  • Teligent Inc
  • MORE
Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Flexion Therapeutics Inc (Flexion) develops and commercializes pain therapies. The company's pipeline is focused on indications that include osteoarthritis knee pain (repeat administration), osteoarthritis knee synovial inflammation, bilateral knee osteoarthritis pain shoulder and hip osteoarthritis pain and inflammatory conditions. The company’s marketed product includes Zilretta which is the first and only extended-release, intra-articular therapy for patients facing with osteoarthritis-related knee pains. Flexion employs its proprietary microsphere technology to combine triamcinolone acetonide (TA) with a polylactic-co-glycolic acid (PLGA) matrix for formulating Zilretta. Its pipeline product candidate FX201 is being developed for treating pain caused from osteoarthritis of the knee and inflammatory conditions. The company markets Zilretta in the US through its own sales and marketing organization and distributors. Flexion is headquartered in Burlington, Massachusetts, the US.

Flexion Therapeutics Inc Key Recent Developments

Aug 05, 2020: Flexion Therapeutics reports second-quarter 2020 financial results and recent business highlights
Jul 14, 2020: Flexion Therapeutics announces preliminary second-quarter 2020 ZILRETTA net sales
May 07, 2020: Flexion Therapeutics reports first-quarter 2020 financial results and recent business highlights
Mar 12, 2020: Flexion Therapeutics reports fourth-quarter and full-year 2019 financial results
Mar 11, 2020: Flexion Therapeutics names Melissa Layman Chief Commercial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Ampio Pharmaceuticals Inc
  • Anika Therapeutics Inc
  • Bionpharma Inc
  • Halyard Health Inc
  • Teligent Inc
  • MORE
Section 1 - About the Company
  • Flexion Therapeutics Inc - Key Facts
  • Flexion Therapeutics Inc - Key Employees
  • Flexion Therapeutics Inc - Key Employee Biographies
  • Flexion Therapeutics Inc - Major Products and Services
  • Flexion Therapeutics Inc - History
  • Flexion Therapeutics Inc - Company Statement
  • Flexion Therapeutics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 – Company Analysis
  • Company Overview
  • Flexion Therapeutics Inc - Business Description
  • Flexion Therapeutics Inc - Corporate Strategy
  • Flexion Therapeutics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Flexion Therapeutics Inc - Strengths
  • Flexion Therapeutics Inc - Weaknesses
  • Flexion Therapeutics Inc - Opportunities
  • Flexion Therapeutics Inc - Threats
  • Flexion Therapeutics Inc - Key Competitors
Section 3 – Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
  • Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
  • Flexion Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
  • Aug 05, 2020: Flexion Therapeutics reports second-quarter 2020 financial results and recent business highlights
  • Jul 14, 2020: Flexion Therapeutics announces preliminary second-quarter 2020 ZILRETTA net sales
  • May 07, 2020: Flexion Therapeutics reports first-quarter 2020 financial results and recent business highlights
  • Mar 12, 2020: Flexion Therapeutics reports fourth-quarter and full-year 2019 financial results
  • Mar 11, 2020: Flexion Therapeutics names Melissa Layman Chief Commercial Officer
  • Dec 10, 2019: Flexion Therapeutics announces the retirement of Neil Bodick, M.D., Ph.D., chief scientific officer and company co-founder 2019
  • Nov 07, 2019: Flexion Therapeutics reports third-quarter 2019 financial results and recent business highlights
  • Sep 10, 2019: Flexion Therapeutics licences pain therapy from Xenon
  • Aug 06, 2019: Flexion Therapeutics reports second-quarter 2019 financial results and recent business highlights
  • May 08, 2019: Flexion Therapeutics reports first-quarter 2019 financial results and recent business highlights
Section 6 – Appendix
  • Methodology
  • Ratio Definitions
  • About the Publisher
  • Contact
  • Disclaimer
List of Tables
  • Flexion Therapeutics Inc, Key Facts
  • Flexion Therapeutics Inc, Key Employees
  • Flexion Therapeutics Inc, Key Employee Biographies
  • Flexion Therapeutics Inc, Major Products and Services
  • Flexion Therapeutics Inc, History
  • Flexion Therapeutics Inc, Subsidiaries
  • Flexion Therapeutics Inc, Key Competitors
  • Flexion Therapeutics Inc, Ratios based on current share price
  • Flexion Therapeutics Inc, Annual Ratios
  • Flexion Therapeutics Inc, Annual Ratios (Cont...1)
  • Flexion Therapeutics Inc, Interim Ratios
  • Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
  • Flexion Therapeutics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Flexion Therapeutics Inc, Performance Chart (2015 - 2019)
  • Flexion Therapeutics Inc, Ratio Charts
  • Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
  • Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
Note: Product cover images may vary from those shown
3 of 3
  • Teligent Inc
  • Regeneron Pharmaceuticals Inc
  • Halyard Health Inc
  • Centrexion Therapeutics Corp
  • Ampio Pharmaceuticals Inc
  • Bionpharma Inc
  • Anika Therapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll